This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

NewAge Croissance future

Future contrôle des critères 0/6

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Personal Products croissance des bénéfices	25.3%
Taux de croissance des recettes	n/a
Rendement futur des capitaux propres	n/a
Couverture par les analystes	None
Dernière mise à jour	n/a

Mises à jour récentes de la croissance future

Recent updates

NewAge files for chapter 11 bankruptcy

Aug 30

NewAge receives Nasdaq notice for non-compliance

Aug 18

New Age: 4 Catalysts That We Like Including A Valuation That Is Too Cheap To Ignore

Jul 05

Party Time: Brokers Just Made Major Increases To Their NewAge, Inc. (NASDAQ:NBEV) Earnings Forecasts

Dec 11

NewAge secures new $30M debt facility, shares slide ~4% premarket

Dec 01

NewAge brings in ARIIX to bolster DTC business

Nov 16

NewAge Was Hot Before Recent Cannabis Resurgence - Will Remain Hot

Nov 13

NewAge EPS misses by $0.08, misses on revenue

Nov 09

Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme NewAge n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.

Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.

Prévisions de croissance des bénéfices et des revenus

OTCPK:NBEV.Q - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
9/30/2021	440	-7	-32	-30	N/A
6/30/2021	403	-19	-17	-16	N/A
3/31/2021	341	-44	-24	-23	N/A
12/31/2020	279	-39	-37	-34	N/A
9/30/2020	248	-101	-46	-41	N/A
6/30/2020	255	-98	-47	-41	N/A
3/31/2020	259	-100	-46	-39	N/A
12/31/2019	254	-90	-37	-32	N/A
9/30/2019	208	-27	-33	-30	N/A
6/30/2019	152	-19	-32	-30	N/A
3/31/2019	99	-11	-29	-28	N/A
12/31/2018	52	-12	-23	-22	N/A
9/30/2018	49	-14	-11	-11	N/A
6/30/2018	51	-11	-8	-8	N/A
3/31/2018	53	-5	-6	-5	N/A
12/31/2017	52	-4	-9	-8	N/A
9/30/2017	51	0	-11	-10	N/A
6/30/2017	50	0	-6	-5	N/A
3/31/2017	36	-4	-2	-2	N/A
12/31/2016	25	-4	1	1	N/A
9/30/2016	15	-3	1	1	N/A
6/30/2016	2	-3	-1	-1	N/A
3/31/2016	2	-1	-1	-1	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de NBEV.Q est supérieure au taux d'épargne ( 2.1% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de NBEV.Q devraient croître plus rapidement que le marché US

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de NBEV.Q devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Données insuffisantes pour déterminer si les revenus de NBEV.Q devraient croître plus rapidement que le marché US.

Croissance élevée des revenus: Données insuffisantes pour déterminer si les revenus de NBEV.Q devraient croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de NBEV.Q devrait être élevé dans 3 ans

This company is no longer active

NewAge Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Consensus forecasts updated

Price target decreased to US$3.33

NewAge, Inc. Provides Revenue Guidance for the Fourth Quarter Ended December 31, 2021

Price target decreased to US$5.50

Forecast breakeven pushed back to 2022

Price target decreased to US$5.00

Recent updates

Rosen Law Firm Files Securities Class Action Lawsuit Against NewAge, Inc

Nasdaq to Delist Common Stock of NewAge

Newage Announces That Its Common Stock Has Ceased Trading on Nasdaq

Motion for Joint Administration Filed by NewAge, Inc.

DIP Financing, LLC entered into an asset purchase agreement to acquire all of the assets from NewAge, Inc. (NasdaqCM:NBEV), Morinda, Inc, Morinda Holdings, Inc. and Ariix LLC for $28 million.

NewAge files for chapter 11 bankruptcy

NewAge Receives Additional Delinquency Notice from Nasdaq on Late Filing of its Form 10-Q

NewAge receives Nasdaq notice for non-compliance

NewAge, Inc. Receives Notice of Default Letter from East West Bank

Less than half of directors are independent

NewAge, Inc. Announces Executive Changes

New Age: 4 Catalysts That We Like Including A Valuation That Is Too Cheap To Ignore

Cologne List® Adds NewAge, Inc.'s Nutrifii™ Renew to Certification List

Newage, Inc. Receives Nasdaq Notice on Late Filing of Its Form 10-Q

NewAge, Inc. announced delayed 10-Q filing

NewAge, Inc. Receives Notification from Nasdaq Related to Delayed Annual Report on Form 10-K

Less than half of directors are independent

NewAge, Inc. Appoints Michele Crocker to its Board of Directors

NewAge, Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Consensus forecasts updated

Price target decreased to US$3.33

NewAge, Inc. Provides Revenue Guidance for the Fourth Quarter Ended December 31, 2021

Is NewAge (NASDAQ:NBEV) Using Debt Sensibly?

Independent Director recently bought US$608k worth of stock

Third quarter 2021 earnings released: US$0.018 loss per share (vs US$0.14 loss in 3Q 2020)

NewAge, Inc. Publishes Major New Discovery on Blocking Spike Proteins from Binding to Human Cells

Health Check: How Prudently Does NewAge (NASDAQ:NBEV) Use Debt?

Price target decreased to US$5.50

Second quarter 2021 earnings released: EPS US$0.12 (vs US$0.10 loss in 2Q 2020)

TCI Co., Ltd. (TPEX:8436) entered into a memorandum of understanding to acquire US manufacturing operations from NewAge, Inc. (NasdaqCM:NBEV) for $3.5 million.

Chief Financial Officer Gregory Gould has left the company

Forecast breakeven pushed back to 2022

Price target decreased to US$5.00

NewAge, Inc. (NasdaqCM:NBEV) completed the acquisition of Aliven Inc.

NewAge, Inc. Launches New Children’s Multivitamin With Better Absorption for Immune System Support

NewAge updates on strong growth for Europe business

NewAge Launches New Ocean Friendly, Safe and Effective Sunscreen to the Lucim™ Skincare Line

NewAge, Inc. announced delayed annual 10-K filing

NewAge, Inc. (NasdaqCM:NBEV) entered into an agreement to acquire Aliven Inc. for $2.8 million.

Koios Beverage Corp. Enters into A Distribution Agreement with Newage, Inc

The NewAge (NASDAQ:NBEV) Share Price Is Up 880% And Shareholders Are Delighted

NewAge, Inc. announced that it expects to receive $57.960469 million in funding

NewAge, Inc. to Report Q4, 2020 Results on Mar 16, 2021

New 90-day high: US$3.56

Party Time: Brokers Just Made Major Increases To Their NewAge, Inc. (NASDAQ:NBEV) Earnings Forecasts

NewAge secures new $30M debt facility, shares slide ~4% premarket

NewAge, Inc. Announces Board Changes

New Age Beverages Corporation (NasdaqCM:NBEV) completed the acquisition of ARIIX Holdings, LLC from certain members of Ariix Holdings, LLC.

NewAge brings in ARIIX to bolster DTC business

NewAge Was Hot Before Recent Cannabis Resurgence - Will Remain Hot

Earnings beat expectations, revenue disappoints

Third quarter 2020 earnings released: US$0.14 loss per share

NewAge EPS misses by $0.08, misses on revenue

New 90-day high: US$3.00

NewAge, Inc. to Report Q3, 2020 Results on Nov 09, 2020

New 90-day high: US$2.43

New Age Beverages Corporation (NasdaqCM:NBEV) entered into an agreement to acquire ARIIX Holdings, LLC from certain members of Ariix Holdings, LLC for approximately $280 million.

Zachert Private Equity GmbH acquired all of the membership interests in Brands Within Reach, LLC (BWR) from NewAge, Inc. (NasdaqCM:NBEV) in a deal valued at $15 million.

First half earnings released

NewAge, Inc. to Report Q2, 2020 Results on Aug 10, 2020

New 90-day high - US$2.46

Price target raised to US$6.00

Prévisions de croissance des bénéfices et des revenus

Prévisions de croissance des analystes

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

Découvrir les entreprises en croissance